Chongqing Taiji Industry(Group) Co.,Ltd (600129.SS)

CNY 25.79

(0.31%)

Market Cap (In CNY)

14.36 Billion

Revenue (In CNY)

15.43 Billion

Net Income (In CNY)

822.12 Million

Avg. Volume

12.82 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
19.98-50.33
PE
-
EPS
-
Beta Value
0.621
ISIN
CNE000000TQ2
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Min Yu
Employee Count
-
Website
https://www.taiji.com
Ipo Date
1997-11-18
Details
Chongqing Taiji Industry(Group) Co.,Ltd operates in the pharmaceutical industry in China and internationally. It researches, develops, produces, and sells Chinese medicine and health products. The company offers its products in various dosage forms, including tablets, oral liquids, syrups, dripping pills, granules, capsules, tinctures, powders, etc. It offers its products in various areas, such as digestive system, respiratory system, cardiovascular and cerebrovascular, pediatrics and gynecology, systemic anti-infective drugs, analgesia and antibiotics, orthopedics, cold clearing and cough relief, and endocrine and nervous system drugs. The company is based in Chongqing, China.